2RMJ

Solution structure of RIG-I C-terminal domain

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
2	2D 1H-13C HSQC	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
3	3D CBCA(CO)NH	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
4	3D C(CO)NH	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
5	3D HNCO	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
6	3D HNCA	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
7	3D HNCACB	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
8	3D HBHA(CO)NH	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
9	3D HN(CO)CA	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
10	3D H(CCO)NH	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
11	3D HCCH-TOCSY	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
12	3D 1H-15N NOESY	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
13	3D 1H-13C NOESY	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
14	CCH-TOCSY	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
15	(HB)CB(CGCD)HD	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288
16	HNCAHA	0.5mM [U-100% 13C; U-100% 15N] RIG-I	90% H2O/10% D2O	0.25	7		288

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	800
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
torsion angle dynamics, distance geometry, simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
2	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.